ANAWA Trading SA

AcZon is an Italian Company specializing in biotechnology that develops, produces and commercializes Silica Nanoparticles (Nanoprobes) - for diagnostic, clinical and research fields- as well as a range of conventional reagents optimized for various applications as, for example, fluorescent antibodies. People’s Health is the main focus and ultimate goal of our business; our “mission” is basically “To promote and providing Reagents for Diagnostics and Research, with very high brilliance and clarity of image, stability and sensitivity, by offering products and services that speed-up the diagnostic response time, provide a better service to the patient”. AcZon focuses with growing interest on the amazing potentials offered by combining chemistry, biotechnology and nanotechnology. Indeed, on this basis, AcZon has developed and optimized a line of new products (reagents for in vitro diagnostics and research) characterized by outstanding performances. Thanks to its team of researchers (chemists and biologists), all with considerable experience in the synthesis and functionalization of polymers and in the fields of immunology, proteins and bio-conjugations, AcZon has developed, and is now producing, a line of NanoProbes (proprietary technology), based on Silica NanoParticles (NPs), which are not exclusively suitable for diagnostic and clinical applications, but also for chemistry, pharmacy, agriculture and the environment

Pioneer in antibodies’ field, Agro-Bio provides you its expertise and its know-how for production, development and characterization of antibodies. For over 40 years, our team supports pharmaceutical and in vitro diagnostic industries as well as public institutions for their immunology issues. We collaborate both to offer you the most suitable and effective solution. Our goal is the success of your projects.

Our services around antibody:
• Bioanalysis/Biopharma:
o Anti-idiotypic antibodies for positive control, PK and potency test,
o Host Cell Protein issue management: specific anti-HCP antibodies, 2D Western Blot coverage analysis, specific ELISA kit,
o Epitope mapping,
o In vitro production.
• In vitro diagnostic:
o Bulk antibody production,
o Specific polyclonal and monoclonal antibody development,
o Characterization of antibodies: Biacore T200…

Our key strengths to ensure a quality work:
• Over 40 years’ experience in antibody area,
• Responsive, multi-skilled and comprehensive team,
• Certifications ISO 90001:2015 and ISO 13485:2016,
• Research Taxe Credit approval,
• Preserved intellectual propriety and confidentiality,
• Transparency for monitoring and management of your project,
• Royalty-free services.

Antibody Solutions is a privately held American contract research organization that helps biopharmaceutical companies advance their discovery of better diagnostics and therapeutics by delivering fit-for-purpose antibodies. The company provides comprehensive project management and technical support in a fee-for-service model. Antibody Solutions has expertise in immunology, immunochemistry, biochemistry, molecular biology, cell biology, transgenic animal platforms, flow cytometry, recombinant expression, and bioreactor technology. Antibody Solutions has served more than 500 clients, including all of the top 10 global pharmaceutical companies. Founded in 1995, the company is headquartered in Santa Clara, Calif. and works with clients worldwide.

A leading developer of therapeutic, biomarker and critical reagent antibodies, Antibody Solutions provides elements vital for successful antibody discovery, including:

Antigen design and generation
Monoclonal and polyclonal antibody generation
Monoclonal and polyclonal antibody production and purification
Biological characterization (sensitivity, specificity, agonist/antagonist activity, internalization)
Physico-chemical characterization (affinity, amino acid sequence, purity)
Conjugation of antibodies and proteins
Antibody engineering and recombinant expression
Analytical methods development (ELISA, Flow Cytometry, PK/PD, ADA, Flourescence-Activated Cell Sorting)

The company offers 24/7/365 online project management and tracking service.

Biosensis specializes in antibodies and reagents for Neuroscience. Our
neuroscience portfolio includes products for research in neurodegenerative
diseases, neurodevelopment,and neuro-metabolism. Areas of focus include
Alzheimer's, Parkinson's and ALS diseases, as well as autophagy and
metabolic and stress disorders including metabolic syndrome research,
obesity, and neuroimmunology and inflammation with particular emphasis on
neurotrophins and neurotrophin receptors for which Biosensis has been the
worldwide leader and OEM supplier for more than 30 years.
Biosensis also offers more than 200 high-quality ELISA kits for a wide range
of protein targets. Our assays are validated for a variety of sample matrices and where possible, tested by independent research laboratories. Our ELISA kits are complete, ready-to-use and without the need for additional reagents, buffers or plates. Plus our strip format allows you to only use what you need! Our detailed protocols include extensive information about sample preparation, assay execution, data analysis and validation. Full technical support is also provided by our highly skilled technical team at biospeak@biosensis.com.

Our new range of RapidTM ELISA assays can be performed in less than 4 hours
without compromising on accuracy, specificity and sensitivity. These assays
target potential biomarkers, such as oligomeric Aβ peptides (Alzheimer's
Disease, AD), mature BDNF (psychiatric disorders), proNGF (cancer) and
p75NTR/NGFR (Amytrophic Lateral Sclerosis, ALS).
Why purchase from Biosensis?
Biosensis is a company formed by a team of life scientists and business
people dedicated to the support of researchers in academia and industry
worldwide. The team has a combined total of over 50 years experience in the
commercialization of life science reagents for the life science research and diagnostic markets. We are therefore able to offer a level of customer support and expertise unmatched in the neuroscience reagent industry.

Columbia Biosciences Corporation, founded in 2007, develops and manufactures fluorescent proteins, antibody conjugates and novel protein purification ligands. In addition, our comprehensive custom services include antibody labeling, protein purification and discovery services such as functional cell based assays for pre-clinical drug development in oncology and immunology. Our expertise lies in the ability to integrate microalgae cultures with the isolation and purification of algal fluorophores, and with the conjugation of these and other fluorophores to antibodies. Columbia Biosciences’ fluorophores are integrated into a large number of life science products and diagnostic tools and are distributed globally.